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Introduction 
The fluid-regulating systems of the body have been of interest to space 
medicine researchers since results from the earliest flights indicated 
significant changes in this area (Berry et al. 1966; Dietlein and Harris 
1966; Lutwak et al. 1969). The virtual absence of gravity causes a 
decrease in posturally induced hydrostatic force in the extremities, which 
leads to cephalad redistribution of blood. This redistribution is thought to 
be responsible for most of the spaceflight-induced changes in fluid and 
electrolyte metabolism. Plasma volume decreases (Johnson 1979) and 
water and electrolyte balances become negative (Leach 1979) in space 
travelers. In addition to these clear-cut effects, more complex and subtle 
changes in renal and circulatory dynamics, endocrine function , body 
biochemistry, and metabolism occur during spaceflight. 
Two Phases of the Adaptation Process 
Studies in which weightlessness is simulated by decreasing lower-
extremity hydrostatic forces (as by bed rest or water immersion) have 
indicated the presence of at least two phases in the adaptation of the fluid 
and electrolyte homeostatic systems to microgravity (Leach et al. 1983). 
The "acute" phase is believed to occur within a few hours of attaining 
weightlessness. Since it has been difficult for astronauts to perform 
experiments early in a fl ight, most of the evidence for existence of this 
phase has come from simulation studies. Bed-rest studies (Leach et al. 
1983; Nixon et al. 1979) have shown that central venous pressure (CVP) 
increases as early as 5 min after bed rest begins (Nixon et al. 1979). This is 
followed by an increase in the size of the left ventricle, but there is no 
change in cardiac output or arterial pressures (Nixon et aI. 1979). The 
increased CVP is thought to be interpreted physiologically as an increase 
in total blood volume. Glomerular filtration rate (GFR) decreases by 
about 2 hr and effective renal plasma flow (ERPF) by 4 hr, but both return 
to pre-bed-rest levels by 8 hr. Plasma aldosterone and antidiuretic 
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hormone (ADH) decrease between 1 and 6 hr after the beginning of bed 
rest (Leach et al. 1983; Nixon et al. 1979). 
The trans ient acute phase, found in simulation studies and confirmed by 
recent Spacelab data to be discussed below , leads to a later " adaptive" 
phase. Evidence for the existence of the adaptive phase has come from 
blood and urine samples taken in-flight during Gemini , Apollo , Skylab , 
and Spacelab missions. 
Early Spaceflight Findings 
Data from limited in-flight samples, along with preflight and postflight 
measurements of many physiological parameters , provided evidence that 
mass is lost , water balance becomes negative , electrolytes and certain 
minerals are depleted , and cardiovascular deconditioning occurs as a 
result of weightlessness (Berry et al. 1966; Hoffler 1977; Leach et aJ. 
1975). Fluid , potassium, and nitrogenous compounds were apparently lost 
from cells as well as from blood (Leach et al. 1975). Levels of some of the 
hormones involved in regulating fluid and electrolyte balance were 
altered; for example , urinary ADH and aldosterone and plasma angioten-
sin were increased postflight. Plasma volume and red cell mass decreased , 
and orthostatic tolerance and exercise capacity were reduced (Hoffler and 
Johnson 1975). 
Skyiab 
Experiments for Skylab were planned to document the time course of 
known physiological changes and to measure additional parameters 
during long flights . Intake of fluid and nutrients during flight was carefully 
monitored. 
The first in-flight measurements of body mass were performed on 
Skyl&b (Thornton and Ord 1977) . The crew members lost an average of 
2.8 kg, 3.8% of preflight body mass , during flight (Leach and Rambaut 
1977). About half the loss of body mass occurred during the first 2 days of 
flight, with the rest of the loss being more gradual but continuing 
throughout the missions. Depletion of water was thought to be responsi-
ble for the rapid phase of mass loss and depletion of fat and protein for the 
slow phase (Leach and Rambaut 1977). 
Increased urinary excretion of water was expected to account for the 
water deficit. Surprisingly , urinary excretion decreased during the first 10 
days of the missions , and free water clearance decreased slightly (Leach 
and Rambaut 1977). Water balance studies showed that the main cause of 
the net body water reduction during the first 2 days of flight was a 
decrease in fluid intake. 
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To investigate the postulated shift of fluid away from the lower 
extremities, the leg volume of Skylab crew members was measured by 
plethysmography (Thornton et al. 1977). It was estimated that in the first 
few days of flight , 1.8 I of fluid disappeared from the legs (Hoffler 1977), 
an amount considerably greater than the 600 to 800 ml redistributed by a 
change in body position (upright to supine or vice versa) (Sjostrand 1953). 
The amount of fluid lost from the legs was almost equal to the total body 
fluid decrement. 
The loss of so much body fluid implies that levels of other blood and 
tissue components are reduced also. Plasma osmolality and levels of 
sodium and chloride were decreased during flight , and the amounts of 
sodium, potassium, calcium, phosphate , and magnesium were increased 
in 24-hr urine pool s collected in-flight. Leach and Rambaut (1977) 
calculated that approximately 100 meq of sod ium were lost from the 
extracellular space. Electrolytes and other cell constituents may have 
been translocated from cells to blood. Plasma levels of potassium , 
calcium, and phosphate increased during flight. 
Plasma angiotensin and urinary a ldosterone and cortisol were increased 
over their preflight levels during the whole flight but were particularly 
increased at the beginning of each flight (Leach and Rambaut 1977). These 
hormones are released in response to stress and to changes in plasma 
osmolality and electrolytes. Increased angiotensin and aldosterone may 
have caused at least part of the increased urinary excretion of potass ium, 
but it is unusual for high level s of aldosterone to be associated with 
increased sodium excretion. Urinary excretion of antidiuretic hormone 
(ADH) was decreased during flight , another unexpected finding because 
the loss of fluid would normally stimulate ADH secretion , and hyponatre-
mia persisted in spite of the apparent reduction in ADH. 
Renal function was not measured directly during the Skylab flights. 
Slight increases in creatinine clearance (Leach 1981) , decreased urinary 
and plasma uric acid , and increased plasma angiotensin indicated that 
rer.al function may be affected by weightlessness. 
Recent Findings from the Space Shuttle 
Several experiments involving fluid and electrolyte physiology have now 
been performed aboard the space shuttle. Venous pressure was measured 
for the first time on Spacelab 1,22 hr after launch (Kirsch et al. 1984). At 
that time venous pressure was lower than it was on the day before launch. 
Measurement of central and peripheral venous pressures J and J 2 hr after 
landing indicated that fluid redi stribution after reexposure to gravity was 
completed between these times. If redistribution caused by microgravity 
takes about the same amount oftime, it is probably complete before 22 hr . 
Studies of body fluid changes during spaceflight have been hampered by 
lack of knowledge about changes in circadian rhythm and by flight-related 
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problems such as space adaptation syndrome or crew members being on 
different work/rest cycles or being unable to draw blood very soon after 
reaching orbit or at the same time each day . 
In one experiment a mission specialist collected his urine as pools 
representing 5 to 26 hr, and the excretion rates of electrolytes and 
selected hormones were determined . The earliest change detected in this 
study was a transient increase in the excretion rate of ADH in the first 
in-flight sample. This was closely followed by a transient increase in the 
excretion rate of cortisol. Sodium excretion decreased on the day after 
the peak in cortisol excretion occurred , but later in the flight it increased. 
Potassium excretion increased at the same time as cortisol excretion on 
the first day of flight, with smaller peaks on later flight days. Some of 
these changes may have been caused or affected by the presence of space 
adaptation syndrome. On the sixth and last day of the flight , aldosterone 
excretion rate tripled, and cortisol and ADH excretion rates increased by 
lesser amounts. The excretion rates of fluid , potassium, chloride, cal-
cium, and magnesium increased at the same time. The loss of sodium , 
which might be expected to result in increased aldosterone secretion, was 
no greater late in the flight than it had been during the preflight period. 
On the Spacelab flights, blood samples were drawn 22 or more hours 
after launch. Aldosterone, cortisol, and ADH were measured in blood 
samples from Spacelab 1 by Dr. K.A . Kirsch (personal communication), 
and our laboratory has measured the e and other hormones as well as 
serum osmolality, sodium, and potassium in other Spacelab experiments. 
The four crew members on Spacelab I who participated in experiments 
were on two different work/rest cycles , but their blood samples were 
taken at the same clock time, and studies of the circadian rhythms of 
several urinary variables showed that the circadian rhythm of metabolic 
functions did not change (Leach, Johnson , & Cintron 1985). Blood 
samples were obtained from four mission and payload specialists on 
Spacelab 2 and two mission specialists on Spacelab 3. The crew members 
on Spacelab 2 were on two different worklrest cycles, and during flight 
they collected blood samples during the postsleep activity period. This 
was 6:30 or 7:00 a. m. Houston time for two crew members and 5:00 or 
6:00 p.m. for the other two. Because of differences in sample collection 
times, one must be cautious in interpreting the results , but the small 
number of subjects and time points in anyone experiment makes it 
desirable to examine the results of these three experiments together. 
The combined results for all three Spacelab studies (Leach et al. 1985) 
showed that hyponatremia developed within 20 hr after the onset of 
weightlessness and continued throughout the flights , and hypokalemia 
developed by 40 hr. Serum potassium returned to preflight levels later and 
then increased. Serum chloride was decreased on most in-flight days on 
which it was measured, but it immediately returned to preflight levels on 
landing day. 
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shuttle experiment described above and decreased in urine during Skylab 
flights (Leach and Rambaut 1977) and in plasma during bed rest (Nixon et 
al. 1979) , was increased in plasma throughout the Spacelab flights . 
Aldosterone decreased by 40 hr , but after 7 days it had reached preflight 
levels. Angiotensin I was elevated after 2 days in flight. Cortisol increased 
early but decreased later in the flight. Adrenocorticotrophic hormone was 
increased until the seventh day , when levels of cortisol and aldosterone 
returned to or surpassed baseline. 
Current Problems 
The changes that occur in human fluid and electrolyte physiology during 
the acute and adaptiv.e phases of adaptation to spaceflight are summarized 
in Tables 11 .1 and 11 .2. A number of questions remain to be answered. 
At a time when plasma volume and extracellular fluid volume are 
contracted and salt and water intake is unrestricted , ADH does not 
correct the volume deficit and serum sodium decreases. Change in 
secretion or activity of a natriuretic factor during spaceflight is one 
possible explanation. 
Recent identification of a polypeptide hormone produced in cardiac 
muscle cells which is natriuretic , is hypotensive , and has an inhibitory 
effect on renin and aldosterone secretion (Atarashi et al. 1984; Pall uk et 
al . 1985) has renewed interest in the role of a natriuretic factor. The role of 
this atrial natriuretic factor (ANF) in both long- and short-term variation 
in extracellular volumes and in the inability of the kidney to bring about 
an escape from the sodium-retaining state accompanying chronic cardiac 
dysfunction makes it reasonable to look for a role of ANF in the 
regulation of sodium during exposure to microgravity. Prostaglandin E is 
another hormone that may antagonize the action of ADH (Anderson et al. 
1976). Assays of these hormones will be performed on samples from crew 
members in the future. 
TABLE 11 .1. Acute phase of actual or 
simulated microgravity effects on fluid and 
electrolyte physiology 
Cardiovascular effect (bed rest) 
Increased central venous pressure 
Increased size of left ventricle 
Renal effects (bed rest) 
Decreased GFR 
Decreased ERPF 
Endocrine system changes (Spacelab) 
Increased plasma cortisol 
Decreased plasma angiotensin I 
I 
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T A BLE 11.2. Adaptive phase of 
micrograv ity effects on fluid and electrolyte 





Changes in fluid volumes in m~or body 
compartments 
Decrease in lower body 
Increase in upper body 
Decrease in intracellular water 
Decrease in extracellular fluid 
Negative fluid balance 
Decreased fluid intake 
Increased evaporative water loss 
Decreased renal excretion of water 
Slightly decreased free water clearance 
Decreased total body water 
Electrolyte balance 
Decreased exchangeable body potas ium 
Decreased sodium in ex tracellular space 
Increased excretion of sodium 
Increased excretion of potass ium 





Endocrine system change 
Increased plasma angiotensi n I 
Increased urinary aldosterone 
Increased urinary cortisol 
Increased plasma ADH 
Decreased urinary ADH 
Renal fu nction 
Decreased plasma and urinary uric acid 
Increased creati nine clearance 
'Cardiovascular intolerance to standing , found to occur immediately 
after landing in many astronauts, is thought to be related to loss of fluid 
and electrolytes during weightlessness . In the space shuttle, reentry 
acceleration is experienced in the head-to-foot direction because the crew 
members are sitting upright. The gravitational force in that direction is 
usually about 1.2 times the normal 1.0 G (Nicogossian and Parker 1982). 
The rapid increase in accleration forces during reentry would be expected 
to pull body fluid s toward the legs. If there has been substantial loss of 
body fluid , fluid volume in the upper part of the body may decrease 
enough to cause cardiovascular symptoms. Some of these symptoms 







144 Carolyn S. Leach and Philip C . Johnson, ir. 
adapted to earth ' s gravity before landing. Attempts have been made , with 
some success, by investigators in the United States and Soviet space 
programs to prevent or ameliora te orthostatic intolerance. 
One method tha t has been used to counter the orthostati c intolerance is 
fluid and electrolyte loading. If fluid and electrolytes a re re placed , blood 
vo lume should begin to increase and blood pressure should approach 
preflight levels. This should be done before exposure to the increased 
acceleration during the deorbit period . It is now standard practice for 
U .S . as tronaut to consume the equivalent of a liter of ph ysiological 
saline solution in the form of water and salt tablets before landing is 
initiated . Thi practice has been shown to be effective in reducing the 
severity of symptoms of cardiovascular deconditioning (Bungo e t at. 
1985). Similar countermeasures have been used by cosmonaut s on Soyuz 
mis ions (G rigoriev 1983). 
Another approach to prevention of po tflight orthostatic intolerance is 
the use of lower-bod y negative pressure (LBNP) during flight to bring 
more fluid into the legs ; thi s has been used with some ucce s in the 
Soviet space program (Grigoriev 1983). 
There is now considerable indirect evidence that rena l function is 
alte red during weightlessnes (Leach , Johnson , & Cintr6 n 1985) , but 
direct measurements of renal function have been done only in bed-res t 
s tudies. Rena l function tes ts will be performed in conjunction with 
measurement of hormone , electrolytes , plasma volume , and other 
fac tors on Spacelab miss ion in the future. Intake of food and water will 
be measured throughout the mi ss ion , and urine will be co llected void by 
vo id . Blood samples will be taken a t interva ls , beginning a t 3 hr after 
launch , a nd the first renal func tion test will start at 3.5 hr . A catheter to 
measu re central venous pressure will be in serted before launch and 
removed 12 hr into the flight. Plasma volume and extracellula r fluid will be 
meas ured on the second and sixth days of fligh t. These integra ted 
experiments are expected to provide information important for under-
tanding what happens in both phases of the fluid and electrol yte response 
to weightlessness . 
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